dose for microdosing tirzepatide Instructions Compounded Tirzepatide+ Microdosing Tirzepatide: Dose & Genetic

Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists

For comparisons between two specific groups, the MannWhitney U test was applied

ELIJA LA QUE NECESITE

Endpoints The primary outcome measure was the incidence and severity of treatment-emergent AEs through week 16 for the single-dose part of the study and through week 40 for the multiple-dose part of the study

At Perfect B, we use NAD injections rather than IV drips for most patients because the subcutaneous delivery is more practical in a protocol context and the bioavailability is reliable